Article Details
Retrieved on: 2024-08-23 19:37:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The vaccine, known as BNT116 and developed by BioNTech, is designed to target non-small cell lung cancer (NSCLC), the most common type of lung cancer.
Article found on: www.aa.com.tr
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here